Articles from Business Wire (September 3, 2006)

Title	Author	Type	Words
Landmark European Trial Further Demonstrates That Cardiac Resynchronization Therapy (CRT) Reduces Morbidity and Mortality in Patients with Heart Failure.			1119
New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of Secondary Stroke by Almost 50 Percent in High-Risk Type 2 Diabetes Patients.			875
SonoSite Highlights Physician's Study Evaluating Heart Disease Risk; Physician Concludes That Vascular Ultrasound Screening Identifies Heart Disease Risk among Women with Greater Accuracy; Findings Presented at World Congress of Cardiology.			1011